Light-chain (AL) has a worse prognosis than transthyretin (ATTR) cardiac amyloidosis. We compare post-OHT survival for AL and ATTR amyloidosis, hypothesizing that AL would have worse outcomes. 39 patients with… Click to show full abstract
Light-chain (AL) has a worse prognosis than transthyretin (ATTR) cardiac amyloidosis. We compare post-OHT survival for AL and ATTR amyloidosis, hypothesizing that AL would have worse outcomes. 39 patients with cardiac amyloidosis (AL, n = 18; ATTR, n = 21) and 1023 non-amyloidosis subjects
Keywords:
amyloidosis;
light chain;
outcomes heart;
heart transplantation
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!